Skip to main content
Journal cover image

Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.

Publication ,  Journal Article
Omotosho, YB; Vikram, NU; Wright, EC; Dola, V; Abbas, W; Tora, R; Bliss, L; Cochran, C; Pieper, CF; Chittiboina, P; Weinstein, LS; Simonds, WF ...
Published in: J Clin Endocrinol Metab
January 7, 2026

CONTEXT: Patients with Multiple Endocrine Neoplasia Type 1 (MEN1) are genetically predisposed to developing tumors of the parathyroid, pancreas, and anterior pituitary. While widespread genetic testing has increased early diagnoses, the value of radiological surveillance for pituitary adenomas in these patients remains unclear. OBJECTIVE: To investigate the impact of pituitary MRI findings on patient management in MEN1. DESIGN: Retrospective Longitudinal Cohort Study. SETTING: NIH Clinical Center. PATIENTS: Genetically confirmed MEN1 evaluated between 1977- September 2024. MEASURES: Cumulative proportion and rate of intervention for non-functional adenomas. RESULTS: 320 patients with a mean follow-up duration of 14 ± 12 years were identified. 182/320 patients (57%) had pituitary adenomas, of whom 95/182 (52%) had non-functional adenomas. All patients with adenoma had biochemical evaluation at the time of pituitary MRI. There were 21/95 (22%) patients with non-functional adenomas that needed an intervention throughout their follow-up. The rate of intervention per 100 patient years for non-functional adenomas was 3.1% (CI 2.0-4.7%). All patients with non-functional adenoma who required an intervention reported symptoms or had an abnormal pituitary function test. Tumor volume of 38/48 (79%) non-functional adenomas followed over a mean of 8.3 ± 6.1 years remained stable. Only 42/518 (8.1%) MRIs for non-functional adenomas were prompted by clinical or biochemical abnormalities. Individualized imaging could have avoided approximately four MRIs per patient with non-functional micro-adenoma over their follow-up. CONCLUSION: In an overwhelming majority of patients with MEN1, radiological surveillance for non-functional pituitary adenomas offers minimal added benefit beyond patient-reported symptoms and pituitary function testing.

Duke Scholars

Published In

J Clin Endocrinol Metab

DOI

EISSN

1945-7197

Publication Date

January 7, 2026

Location

United States

Related Subject Headings

  • Endocrinology & Metabolism
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Omotosho, Y. B., Vikram, N. U., Wright, E. C., Dola, V., Abbas, W., Tora, R., … Jha, S. (2026). Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaf704
Omotosho, Yetunde B., Nayan U. Vikram, Elizabeth C. Wright, Venkata Dola, Wafa Abbas, Rana Tora, Lynn Bliss, et al. “Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.J Clin Endocrinol Metab, January 7, 2026. https://doi.org/10.1210/clinem/dgaf704.
Omotosho YB, Vikram NU, Wright EC, Dola V, Abbas W, Tora R, et al. Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study. J Clin Endocrinol Metab. 2026 Jan 7;
Omotosho, Yetunde B., et al. “Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.J Clin Endocrinol Metab, Jan. 2026. Pubmed, doi:10.1210/clinem/dgaf704.
Omotosho YB, Vikram NU, Wright EC, Dola V, Abbas W, Tora R, Bliss L, Cochran C, Pieper CF, Chittiboina P, Weinstein LS, Simonds WF, Biassou N, Jha S. Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study. J Clin Endocrinol Metab. 2026 Jan 7;
Journal cover image

Published In

J Clin Endocrinol Metab

DOI

EISSN

1945-7197

Publication Date

January 7, 2026

Location

United States

Related Subject Headings

  • Endocrinology & Metabolism
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences